Activated Partial Thromboplastin Time Kit

Coagpia APTT-N

We created this page for medical staff.

  • *Read carefully the package insert before use.

Performance Data

Within-run reproducibility

[s]
  Sample 1 Sample 2
1 31.3 59.2
2 31.8 60.3
3 31.7 61.0
4 32.0 60.8
5 31.3 60.8
6 32.1 60.3
7 32.1 60.6
8 31.9 60.6
9 31.5 60.5
10 32.0 60.3
Mean 31.8 60.4
S.D. 0.31 0.50
C.V. (%) 1.00 0.83
Max. 32.1 61.0
Min. 31.3 59.2
Range 0.8 1.8

On-Board Stability (After Reconstitution)

[on Coapresta 2000]

On-Board Stability (After Reconstitution)

Interference

  Concentration Measured Value(s)
Base Plasma Spiked Plasma
Unconjugated Bilirubin 20 mg/dL 28.0 28.5
Conjugated Bilirubin 20 mg/dL 28.3 28.4
Hemoglobin 500 mg/dL 28.5 28.2
Chyle 3000 FTU 28.3 28.4

LA Sensitivity (Mixing Study)

Using CP2000's multipoint dilution function, LA positive samples and coagulation factor deficient plasma were measured at 7 points. LA positive sample produces a concave graph while the coagulation factor deficient sample produces a convex graph.

LA Sensitivity (Mixing Study)

Heparin Sensitivity

Heparin Sensitivity

Correlation

Correlation

Assay Procedure

Assay Procedure

"Coagpia" is a trademark or registered trademark of SEKISUI MEDICAL CO., LTD. in Japan and/or other countries.
"Coapresta" and all related logos are trademarks or registered trademarks of SEKISUI MEDICAL CO., LTD. in Japan and/or other countries.

We prepared this page for medical staff (doctors, dentists, pharmacists, clinical laboratory technicians, nurses, etc.) in Japan to ensure the correct use of our products. You should be aware that the information provided is not intended for overseas medical staff and the general public.